Cargando…

Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Poncet, David, Hessler, Catherine, Liang, Hong, Gautheron, Sylviane, Sergent, Michelle, Rintala, Nicholas D., Seydoux, Emilie, Huang, Po-Wei D., Argilla, David, Ruiz, Sophie, Heinrichs, Jon, Maciel, Milton, Orr, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486917/
https://www.ncbi.nlm.nih.gov/pubmed/32983577
http://dx.doi.org/10.1038/s41541-020-00228-w
_version_ 1783581401625395200
author Poncet, David
Hessler, Catherine
Liang, Hong
Gautheron, Sylviane
Sergent, Michelle
Rintala, Nicholas D.
Seydoux, Emilie
Huang, Po-Wei D.
Argilla, David
Ruiz, Sophie
Heinrichs, Jon
Maciel, Milton
Orr, Mark T.
author_facet Poncet, David
Hessler, Catherine
Liang, Hong
Gautheron, Sylviane
Sergent, Michelle
Rintala, Nicholas D.
Seydoux, Emilie
Huang, Po-Wei D.
Argilla, David
Ruiz, Sophie
Heinrichs, Jon
Maciel, Milton
Orr, Mark T.
author_sort Poncet, David
collection PubMed
description Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reported that a vaccine containing recombinant colonization factor antigen (CfaEB) targeting fimbrial tip adhesin of the colonization factor antigen I (CFA/I) and an attenuated LT toxoid (dmLT) elicited mucosal and systemic immune responses against both targets. Additionally, the toll-like receptor 4 ligand second-generation lipid adjuvant (TLR4-SLA) induced a potent mucosal response, dependent on adjuvant formulation. However, a combination of vaccine components at their respective individual optimal doses may not achieve the optimal immune profile. We studied a subunit ETEC vaccine prototype in mice using a response surface design of experiments (DoE), consisting of 64 vaccine dose-combinations of CfaEB, dmLT and SLA in four formulations (aqueous, aluminium oxyhydroxide, squalene-in-water stable nanoemulsion [SE] or liposomes containing the saponin Quillaja saponaria-21 [LSQ]). Nine readouts focusing on antibody functionality and plasma cell response were selected to profile the immune response of parenterally administered ETEC vaccine prototype. The data were integrated in a model to identify the optimal dosage of each vaccine component and best formulation. Compared to maximal doses used in mouse models (10 µg CfaEB, 1 µg dmLT and 5 µg SLA), a reduction in the vaccine components up to 37%, 60% and 88% for CfaEB, dmLT and SLA, respectively, maintained or even maximized immune responses, with SE and LSQ the best formulations. The DoE approach can help determine the best vaccine composition with a limited number of experiments and may accelerate development of multi-antigen/component ETEC vaccines.
format Online
Article
Text
id pubmed-7486917
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74869172020-09-24 Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments Poncet, David Hessler, Catherine Liang, Hong Gautheron, Sylviane Sergent, Michelle Rintala, Nicholas D. Seydoux, Emilie Huang, Po-Wei D. Argilla, David Ruiz, Sophie Heinrichs, Jon Maciel, Milton Orr, Mark T. NPJ Vaccines Article Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reported that a vaccine containing recombinant colonization factor antigen (CfaEB) targeting fimbrial tip adhesin of the colonization factor antigen I (CFA/I) and an attenuated LT toxoid (dmLT) elicited mucosal and systemic immune responses against both targets. Additionally, the toll-like receptor 4 ligand second-generation lipid adjuvant (TLR4-SLA) induced a potent mucosal response, dependent on adjuvant formulation. However, a combination of vaccine components at their respective individual optimal doses may not achieve the optimal immune profile. We studied a subunit ETEC vaccine prototype in mice using a response surface design of experiments (DoE), consisting of 64 vaccine dose-combinations of CfaEB, dmLT and SLA in four formulations (aqueous, aluminium oxyhydroxide, squalene-in-water stable nanoemulsion [SE] or liposomes containing the saponin Quillaja saponaria-21 [LSQ]). Nine readouts focusing on antibody functionality and plasma cell response were selected to profile the immune response of parenterally administered ETEC vaccine prototype. The data were integrated in a model to identify the optimal dosage of each vaccine component and best formulation. Compared to maximal doses used in mouse models (10 µg CfaEB, 1 µg dmLT and 5 µg SLA), a reduction in the vaccine components up to 37%, 60% and 88% for CfaEB, dmLT and SLA, respectively, maintained or even maximized immune responses, with SE and LSQ the best formulations. The DoE approach can help determine the best vaccine composition with a limited number of experiments and may accelerate development of multi-antigen/component ETEC vaccines. Nature Publishing Group UK 2020-09-11 /pmc/articles/PMC7486917/ /pubmed/32983577 http://dx.doi.org/10.1038/s41541-020-00228-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Poncet, David
Hessler, Catherine
Liang, Hong
Gautheron, Sylviane
Sergent, Michelle
Rintala, Nicholas D.
Seydoux, Emilie
Huang, Po-Wei D.
Argilla, David
Ruiz, Sophie
Heinrichs, Jon
Maciel, Milton
Orr, Mark T.
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title_full Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title_fullStr Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title_full_unstemmed Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title_short Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
title_sort preclinical optimization of an enterotoxigenic escherichia coli adjuvanted subunit vaccine using response surface design of experiments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486917/
https://www.ncbi.nlm.nih.gov/pubmed/32983577
http://dx.doi.org/10.1038/s41541-020-00228-w
work_keys_str_mv AT poncetdavid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT hesslercatherine preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT lianghong preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT gautheronsylviane preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT sergentmichelle preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT rintalanicholasd preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT seydouxemilie preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT huangpoweid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT argilladavid preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT ruizsophie preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT heinrichsjon preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT macielmilton preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments
AT orrmarkt preclinicaloptimizationofanenterotoxigenicescherichiacoliadjuvantedsubunitvaccineusingresponsesurfacedesignofexperiments